xIANDING MA | PARTNER | PARIS

Founder of Cenponts; based in Europe for over 15 years, with a proven track record of leading more than $600 million in cross-border investment and M&A transactions; received a congratulatory letter from the Office of the French President, Emmanuel Macron in 2018.

  • •Domain Therapeutics (Series A Funding: $42M)

    •Avilex Pharma & Simcere (Licensing: $175M)

    •Skymedic & Wondfo (Licensing: $21M)

    •Genfit & Terns Pharma (Licensing: $228M)

    •Pharnext & Tasly (Equity: $30M), etc.

  • •Master Degree, École Centrale Paris & École Nationale des Ponts et Chaussées (IP Paris)